← Open Payments lookup

TERI SCHWARZ: Open Payments

NPI 1487707972 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,058 in 65 payments from 10 companies in 2025. Trend: 2023 $2,654 · 2024 $911 · 2025 $1,058

Food & beverage: $1,058
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.13$229
Alkermes, Inc.10$188
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$149
Teva Pharmaceuticals USA, Inc.8$135
Neurocrine BioSciences, Inc.5$98
Noven Therapeutics, LLC4$71
Vanda Pharmaceuticals Inc.3$71
ABBVIE INC.3$67
E.R. Squibb & Sons, L.L.C.1$28
Axsome Therapeutics, Inc.1$22

Products named: REXULTI, ARISTADA, CAPLYTA, AUSTEDO XR, INGREZZA, Xelstrym, FANAPT, VRAYLAR.

Industry payments across LA — which companies pay providers there.